Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04254107
Title A Safety Study of SGN-TGT in Patients With Advanced Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications

diffuse large B-cell lymphoma

Hodgkin's lymphoma

lymphoma

stomach carcinoma

lung non-small cell carcinoma

peripheral T-cell lymphoma

Therapies

SGN-TGT

Pembrolizumab + SGN-TGT

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN


No variant requirements are available.